Mohammad-Reza Zarrindast Selected Research

Mohammad-Reza Zarrindast Research Topics

Disease

57	Amnesia (Dissociative Amnesia) 06/2021 - 08/2004
16	Memory Disorders (Memory Loss) 12/2021 - 03/2014
14	Pain (Aches) 10/2022 - 01/2006
13	Sleep Deprivation 02/2022 - 01/2016
7	Substance-Related Disorders (Drug Abuse) 10/2020 - 01/2014
6	Opioid-Related Disorders (Opiate Addiction) 07/2015 - 07/2009
5	Alzheimer Disease (Alzheimer's Disease) 05/2022 - 04/2014
5	Cognitive Dysfunction 04/2022 - 11/2013
5	Cholestasis 01/2020 - 06/2013
4	Mental Disorders (Mental Disorder) 01/2022 - 01/2019
4	Morphine Dependence 01/2022 - 09/2002
4	Hypothermia 01/2020 - 09/2002
3	Nervous System Diseases (Neurological Disorders) 04/2022 - 01/2019
3	Mood Disorders (Mood Disorder) 01/2022 - 09/2015
3	Parkinson Disease (Parkinson's Disease) 12/2021 - 01/2012
2	Stroke (Strokes) 04/2022 - 01/2020
2	Multiple Sclerosis 04/2022 - 02/2020
2	Anxiety Disorders (Anxiety Disorder) 01/2022 - 01/2009
2	Inflammation (Inflammations) 01/2022 - 12/2020
2	Neuralgia (Stump Neuralgia) 01/2021 - 12/2018
2	Hepatic Encephalopathy 12/2020 - 10/2016
2	B-Cell Lymphoma (Lymphoma, B Cell) 12/2020 - 01/2020
2	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2020 - 10/2018
2	Neoplasms (Cancer) 07/2020 - 08/2013
2	Hyperalgesia 01/2019 - 05/2003

Drug/Important Bio-Agent (IBA)

37	Morphine (MS Contin)FDA LinkGeneric 01/2022 - 05/2002
14	Pharmaceutical PreparationsIBA 01/2021 - 05/2003
13	Opioid Analgesics (Opioids)IBA 01/2022 - 05/2002
13	Sulpiride (neogama)IBA 12/2021 - 08/2004
12	Naloxone (Narcan)FDA LinkGeneric 01/2020 - 05/2002
11	SCH 23390IBA 09/2019 - 08/2004
8	CannabinoidsIBA 10/2022 - 01/2015
8	Nicotine FDA Link 01/2019 - 05/2002
7	Dopamine (Intropin)FDA LinkGeneric 04/2022 - 09/2002
7	MuscimolIBA 01/2020 - 01/2006
6	Anti-Anxiety Agents (Anxiolytics)IBA 12/2021 - 08/2013
6	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 05/2017 - 05/2010
6	N-Methylaspartate (NMDA)IBA 10/2016 - 12/2008
6	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 02/2016 - 03/2013
5	Therapeutic UsesIBA 04/2022 - 02/2020
5	RS 67333IBA 06/2021 - 03/2014
5	harman (harmane)IBA 09/2019 - 11/2013
5	Messenger RNA (mRNA)IBA 01/2018 - 07/2009
5	Glutamic Acid (Glutamate)FDA Link 01/2017 - 06/2006
5	LithiumIBA 10/2016 - 11/2006
4	AntioxidantsIBA 01/2022 - 01/2020
4	Arginine (L-Arginine)FDA Link 12/2021 - 06/2006
4	NG-Nitroarginine Methyl Ester (L-NAME)IBA 12/2021 - 06/2006
4	Scopolamine (Hyoscine)FDA Link 10/2020 - 05/2010
4	NeuroaidIBA 06/2020 - 01/2019
4	Clonidine (ST 155)FDA LinkGeneric 01/2020 - 07/2003
4	2,3,4,5- Tetrahydro- 7,8- dihydroxy- 1- phenyl- 1H- 3- benzazepine (SKF 38393)IBA 09/2019 - 08/2004
4	Dopamine Receptors (Dopamine Receptor)IBA 01/2019 - 08/2005
4	BicucullineIBA 01/2017 - 01/2006
4	mu Opioid Receptors (mu Opioid Receptor)IBA 04/2014 - 07/2009
3	Tramadol (K315)FDA LinkGeneric 01/2022 - 01/2019
3	Analgesics (Analgesic Drugs)IBA 01/2022 - 01/2018
3	QuinpiroleIBA 12/2021 - 08/2004
3	salicylhydroxamic acid (SHAM)IBA 03/2021 - 06/2013
3	Neuroprotective AgentsIBA 01/2021 - 12/2018
3	AM 251 (AM251)IBA 01/2021 - 03/2013
3	Imipramine (Janimine)FDA LinkGeneric 01/2021 - 07/2003
3	5-HT4 Serotonin ReceptorsIBA 01/2020 - 03/2014
3	Yohimbine (Yocon)IBA 01/2020 - 07/2003
3	Ketamine FDA LinkGeneric 11/2019 - 06/2016
3	Neurotransmitter Agents (Neurotransmitter)IBA 04/2019 - 09/2015
3	Streptozocin (Streptozotocin)FDA Link 01/2019 - 11/2013
3	Dopamine AntagonistsIBA 01/2019 - 08/2013
3	azasetronIBA 09/2017 - 03/2014
3	Dizocilpine Maleate (Dizocilpine)IBA 04/2016 - 06/2006
3	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2016 - 07/2003
3	Ethanol (Ethyl Alcohol)IBA 03/2013 - 12/2008
3	MecamylamineIBA 07/2008 - 05/2002
2	EndocannabinoidsIBA 10/2022 - 01/2006
2	HarmalineIBA 10/2022 - 10/2014
2	Thimerosal (Thiomersal)IBA 06/2022 - 05/2018
2	Serotonin (5 Hydroxytryptamine)IBA 02/2022 - 11/2013
2	Antidepressive Agents (Antidepressants)IBA 01/2022 - 12/2021
2	Oxidopamine (6 Hydroxydopamine)IBA 12/2021 - 12/2021
2	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 12/2021 - 11/2019
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2021 - 06/2006
2	Cytidine Diphosphate Choline (Citicoline)IBA 01/2021 - 10/2018
2	Amyloid (Amyloid Fibrils)IBA 12/2020 - 01/2019
2	NeuropeptidesIBA 06/2020 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2018
2	Opioid Receptors (Opioid Receptor)IBA 01/2020 - 01/2018
2	Malondialdehyde (Propanedial)IBA 01/2020 - 11/2013
2	gamma-Aminobutyric Acid (GABA)IBA 01/2020 - 01/2017
2	Adenosine Triphosphate (ATP)IBA 01/2020 - 12/2006
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2020 - 04/2008
2	Dopamine Agents (Dopaminergic Agents)IBA 09/2019 - 06/2016
2	Cholinergic Agents (Cholinergics)IBA 10/2017 - 01/2006
2	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 10/2017 - 04/2014
2	PhysostigmineIBA 10/2017 - 01/2006

Therapy/Procedure

11	Injections 09/2019 - 08/2004
4	Therapeutics 07/2020 - 07/2009
4	Analgesia 01/2019 - 09/2017
4	Ligation 10/2016 - 06/2013
3	Transcranial Direct Current Stimulation 01/2019 - 11/2017
2	Cognitive Training 04/2022 - 01/2020